Walter Won

8 Patents

• US125654762026

  2,5-disubstituted 3-methyl Pyrazines and 2,5,6-trisubstituted 3-methyl Pyrazines as Allosteric SHP2 Inhibitors

  Revolution Medicines, Inc.

  0 cites
• US125344532026

  Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof

  Maze Therapeutics, Inc.

  0 cites
• US122460082025

  4-amino or 4-alkoxy-substituted Aryl Sulfonamide Compounds with Selective Activity in Voltage-gated Sodium Channels

  Merck Sharp & Dohme LLC

  0 cites
• US121877462025

  C26-linked Rapamycin Analogs as Mtor Inhibitors

  REVOLUTION MEDICINES, Inc.

  0 cites
• US118143672023

  Inhibitors of Glycogen Synthase 1 (GYS1) and Methods of Use Thereof

  MAZE THERAPEUTICS, Inc.

  0 cites
• US117024112023

  Pyridine, Pyrazine, and Triazine Compounds as Allosteric SHP2 Inhibitors

  REVOLUTION MEDICINES, Inc.

  0 cites
• US116857492023

  C26-linked Rapamycin Analogs as Mtor Inhibitors

  REVOLUTION MEDICINES, Inc.

  0 cites
• US116614012023

  2,5-disubstituted 3-methyl Pyrazines and 2,5,6-trisubstituted 3-methyl Pyrazines as Allosteric SHP2 Inhibitors

  REVOLUTION MEDICINES, Inc.

  0 cites